Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v9-EN
Language English English
Date Updated 2018-07-04 2018-07-04
Drug Identification Number 02239131 02239131
Brand name MYLAN-IPRATROPIUM SOLUTION MYLAN-IPRATROPIUM SOLUTION
Common or Proper name IPRATROPIUM SOLUTION IPRATROPIUM SOLUTION
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients IPRATROPIUM BROMIDE IPRATROPIUM BROMIDE
Strength(s) 0.25MG 0.25MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INHALATION INHALATION
Packaging size 20ML 20ML
ATC code R03BB R03BB
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2018-07-03 2018-07-03
Actual discontinuation date 2018-07-03 2018-07-03
Remaining supply date 2018-07-03 2018-07-03
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Discontinued in shortage ID 30371 . Last lot 6G355 Expires 31-Jul-19 Discontinued in shortage ID 30371 . Last lot 6G355 Expires 31-Jul-19
Health Canada comments